Besides CTLA-4, the Programmed Death 1 receptor and its ligand (PD-1/PD-L1) are an IC that was discovered in 1992 by Tasuku Honjo in a mouse T-cell hybrid tumor (89). This evidence concerns the gene CTLA4 and neoplasm.